000			01312 a2200385 4500
005			20250513125955.0
264		0	_c19971021
008			199710s 0 0 eng d
022			_a0093-7754
040			_aNLM _beng _cNLM
100	1		_aLau, D H
245	0	0	_aChemoradiotherapy for poor-risk stage III non-small cell lung cancer. _h[electronic resource]
260			_bSeminars in oncology _cAug 1997
300			_aS12-110-S12-112 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aCarboplatin _xadministration & dosage
650	0	4	_aCarcinoma, Non-Small-Cell Lung _xdrug therapy
650	0	4	_aCombined Modality Therapy
650	0	4	_aEtoposide _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Staging
650	0	4	_aPilot Projects
650	0	4	_aRadiotherapy Dosage
650	0	4	_aSurvival Analysis
700	1		_aRyu, J K
700	1		_aGandara, D R
773	0		_tSeminars in oncology _gvol. 24 _gno. 4 Suppl 12 _gp. S12-110-S12-112
999			_c9303869 _d9303869